US Food and Drug Administration prepares to use blockchain to record product data

The US Food and Drug Administration (FDA) announced that it intends to integrate blockchain technology into the record keeping of consumer product data. The FDA's new announcement confirms a three-step strategy that will consolidate the process of strengthening voluntary recalls. These include trainers, blockchain records, and recall procedures. The draft guide considers the blockchain as an important complement to public health and provides a secure platform for recording data.